Evidence map›Paper›PMID 42755123›Full record

ReviewImmunological reviews2026

BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity.

Daisy H Luff, Edina Schweighoffer, Victor L J Tybulewicz

Abstract readReview
In one paragraph

Review in Immunological reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daisy H LuffThe Francis Crick Institute, London, UK.ORCID https://orcid.org/0000-0002-9622-664X
Edina SchweighofferThe Francis Crick Institute, London, UK.
Victor L J TybulewiczThe Francis Crick Institute, London, UK.ORCID https://orcid.org/0000-0003-2439-0798

Funding

Cancer Research UK CC2080Francis Crick Institute CC2080Medical Research Council CC2080Wellcome Trust CC2080
6 · The paper itself

Abstract

BAFF and APRIL are TNF superfamily proteins that bind to BAFFR, TACI and BCMA, members of the TNF receptor superfamily. These proteins have both unique and overlapping roles in B cell development and survival and are major therapeutic targets for antibody- and B-cell-driven pathologies. BAFF and BAFFR are required for development and survival of follicular and marginal zone (MZ) B cells, whereas BAFF and APRIL acting through TACI and BCMA support plasma cell survival. TACI and BCMA can both be cleaved to generate soluble decoy receptors binding to BAFF or APRIL, forming feedback circuits. Thus, loss of TACI leads to an increase in BAFF, resulting in B cell hyperplasia. Recent work showed that TACI is required for MZ B cell development, a finding that has implications for understanding immune dysfunction in humans. Both monoallelic and biallelic loss-of-function TACI mutations result in immunodeficiency, potentially due to impaired MZ B cell function. Paradoxically, monoallelic TACI mutations predispose to autoimmunity. We propose this may be due to increased BAFF levels which promote selection of self-reactive B cell clones into the mature B cell pool, particularly the MZ B cell compartment. A deeper understanding of this ligand-receptor system is essential for effective therapeutic targeting.

Indexed as

AutoimmunityB-Cell Activating FactorB-Cell Activation Factor ReceptorB-LymphocytesTumor Necrosis Factor Ligand Superfamily Member 13AnimalsB-Cell Maturation AntigenHumansMutationSignal TransductionTransmembrane Activator and CAML Interactor ProteinB-Cell Activating FactorB-Cell Activation Factor ReceptorB-Cell Maturation AntigenTNFSF13B protein, humanTransmembrane Activator and CAML Interactor ProteinTumor Necrosis Factor Ligand Superfamily Member 13APRILautoimmunityBAFFBAFFRBCMAcommon variable immunodeficiencymarginal zone B cellsTACI

Identifiers

PMID42755123
PMCPMC13586541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.